 Altimmune Inc NASDAQ: ALT has expanded its previously-announced manufacturing collaboration with Lonza Group OTCMKT: LZAGY for AdCOVID, its single-dose intranasal COVID-19 vaccine candidate. Under the expansion, Lonza will commission a dedicated manufacturing suite for clinical and commercial production of AdCOVID, at its facility near Houston, Texas. 